The invention herein disclosed relates to the anti-HIV action of uPAR-activators or activated uPAR molecules, the control of chemotaxis and cell migration by agents interfering with uPAR activation, a method for determining activated uPAR forms, the use of agents interfering with uPA/uPAR interaction for the diagnosis or therapy of diseases.

 
Web www.patentalert.com

< Sulfonated block copolymers, method for making same, and various uses for such block copolymers

< Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders

> Uses of monoclonal antibody 8H9

> Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling

~ 00613